Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance (Q38327921)

2 September 2017

Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance (English)

1 reference

2 September 2017

0 references

0 references

3

Markku Laakso

1 reference

2 September 2017

Jelena Zacharova

1

1 reference

PubMed ID

15833934

2 September 2017

Jean-Louis Chiasson

series ordinal

2

1 reference

2 September 2017

1 March 2005

1 reference

2 September 2017

1 reference

2 September 2017

13

1 reference

2 September 2017

3

1 reference

2 September 2017

501-506

1 reference

Leptin and the regulation of body weight in mammals

2 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Exonic and intronic sequence variation in the human leptin receptor gene (LEPR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Congenital leptin deficiency is associated with severe early-onset obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

The common pentanucleotide polymorphism of the 3'-untranslated region of the leptin receptor gene is associated with serum insulin levels and the risk of type 2 diabetes in non-diabetic men: a prospective case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Leptin receptor gene variation and obesity: lack of association in a white British male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

A common pentanucleotide polymorphism of the 3'-untranslated part of the leptin receptor gene generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.52

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.52

1 reference

2 September 2017

1 reference

PubMed ID

15833934